Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases PLEASANTON, Calif. — 10x Genomics (Nasdaq: TXG) strengthened the research toolkit of scientists around the globe today with the launch of its Chromium Single Cell Immune Profiling v2 product. The new product extends the capabilities of the original version, supporting fundamental breakthroughs in immunology, […]

LEIDEN, The Netherlands — Toxys BV is a biotech company based in Leiden, The Netherlands, that provides innovative in vitro toxicity screening solutions to identify carcinogenic and other hazardous properties of compounds for the pharmaceutical, chemical, cosmetics and food industry. Today, Toxys announces the appointment of Susan Swarte as new non-executive member of the Board of Directors. Susan is […]

New BMC Genomics publication validates novel TruDrop approach developed in collaboration with scientists at Vanderbilt University Medical Center and RootPath Genomics WATERTOWN, Mass. – 1CellBio, Inc., announced today a new dual indexed library design capability that improves costs, throughput and data quality for its inDrop™ single-cell RNA sequencing (scRNA-seq) System. The TruDrop capability was developed in collaboration […]

Reduces genomic data storage and transfer costs associated with the data deluge In 2019, the volume of genomic data generated by Illumina’s global installed base of more than 15,000 sequencing systems increased more than 50 percent year-over-year, to 150 petabases. That is the equivalent of 500 years of continuous video recordings in high definition. This […]

Forth Dimension Displays’ LCOS Fast Switching Binary Modulators enable new Ultra-Fast, High-Resolution Microscopes WESTBOROUGH, Mass. – Kopin Corporation (NASDAQ: KOPN), a leading provider of innovative wearable computing technologies and solutions, today announced that its wholly-owned subsidiary Forth Dimension Displays (ForthDD) and Intelligent Imaging Innovations (3i), a Colorado-based manufacturer of fluorescence microscope systems for biomedical research, expanded their […]

Partnership to evaluate the use of Affimer reagents to detect the coronavirus using novel sensors Cambridge and Wetherby, UK: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Integumen plc (AIM: SKIN) (“Integumen”) to evaluate recently generated Affimer reagents that bind […]

Strategic partnership will focus on commercializing CELLSEARCH platform for COVID-19 related use cases, along with other COVID-19 related products BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. and GAITHERSBURG, Md. — OpGen, Inc. (Nasdaq: OPGN), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that it has […]

CARLSBAD, Calif. — Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next-generation sequencing (NGS)–based diagnostics in Russia. The agreement enables First Genetics to market its F-Genetics NGS System and IVD assays to Russian labs for […]

Modern Water is pleased to note that Integumen plc (“Integumen”), the Company’s reagent production agency partner, has entered into a collaboration agreement with Avacta plc (“Avacta”) for the evaluation of Avacta Affimers for the real-time identification of localised COVID-19 hotspots in wastewater, from which authorities can be alerted through Integumen’s real-time alert system to prevent […]

Maennedorf, Switzerland – Tecan is excited to announce an agreement with Thomas Scientific, a distributor of laboratory solutions and equipment, to support the sales of Tecan’s detection instruments and consumables portfolio in the US. This collaboration will allow Tecan to expand its presence for these product lines and reach a wider customer base across the […]